Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiovascular Disease
100%
Protease Inhibitors
100%
Donor-acceptor
100%
Lopinavir
100%
Multi-cohort Study
100%
Cardiovascular Risk Factors
44%
Incidence Rate
33%
Cardiovascular Events
22%
Causal Pathways
22%
Disease Incidence
22%
People Living with HIV (PLHIV)
22%
D Study
22%
Cardiovascular Disease Incidence
22%
Myocardial Infarction
11%
Adverse Events
11%
First-ever
11%
Europe
11%
Increasing Risk
11%
Bilirubin Concentration
11%
Highly Active Antiretroviral Therapy (HAART)
11%
Human Immunodeficiency Virus Type 1 (HIV-1)
11%
Australia
11%
Increased Incidence
11%
Ritonavir
11%
Virological Failure
11%
Sudden Cardiac Death
11%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
11%
Anti-HIV Drugs
11%
Viral Load
11%
Darunavir
11%
Carotid Endarterectomy
11%
Current Analysis
11%
Prospective Data Collection
11%
Atazanavir
11%
Oversight Committee
11%
Causal Inference
11%
Cardiovascular Surgery
11%
Coronary Angioplasty
11%
Coronary Bypass
11%
Myocardial Infarction Stroke
11%
Poisson Regression Model
11%
Follow-up Data
11%
Living with HIV
11%
CD4 Cell Count
11%
Boosted Protease Inhibitor
11%
Contemporary Treatment
11%
Medicine and Dentistry
Cardiovascular Disease
100%
Proteinase Inhibitor
100%
Ritonavir
83%
Darunavir
50%
Atazanavir
41%
Human Immunodeficiency Virus
25%
Myocardial Infarction
16%
Apoplexy
16%
Cardiovascular System
16%
Cell Count
8%
Adverse Event
8%
Coronary Artery Bypass Graft
8%
Highly Active Antiretroviral Therapy
8%
Sudden Cardiac Death
8%
Carotid Endarterectomy
8%
Nonnucleoside Reverse Transcriptase Inhibitor
8%
Anti-Human Immunodeficiency Virus
8%
Bilirubin
8%
Transluminal Coronary Angioplasty
8%
Cardiovascular Procedure
8%
Causal Inference
8%
Pharmacology, Toxicology and Pharmaceutical Science
Proteinase Inhibitor
100%
Cardiovascular Disease
100%
Ritonavir
83%
Darunavir
50%
Atazanavir
41%
HIV
25%
Heart Infarction
16%
Cerebrovascular Accident
16%
Adverse Event
8%
Bilirubin
8%
Sudden Cardiac Death
8%
Nonnucleoside Reverse Transcriptase Inhibitor
8%
Anti-Human Immunodeficiency Virus
8%